News
Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...
Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.
4h
WISH-TV on MSNFor sale: IEDC land purchased for LEAP, never usedThe Indiana Economic Development Corp. has listed two properties for sale in Boone County as part of the LEAP Innovation ...
Efforts to reduce diabetes in three Indianapolis neighborhoods are deemed successful, addressing access, education, and trust.
A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...
Eli Lilly and Company and Purdue University are keeping their partnership alive beyond it’s previously expected years. In an ...
Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
2d
Pharmaceutical Technology on MSNLilly-Purdue partnership to invest $250m in pharma innovationEli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of ...
Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...
Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results